Skip to main content
QTTBHealthcare

Q32 Bio Inc. (QTTB) Insider Trading

In the last 90 days, 3 Q32 Bio Inc. (QTTB) insiders reported no open-market purchases and 6 sales totaling $320,396. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 6, 2026Jodie Pope MorrisonCEOSale3,221$8.32$26,798
Oct 6, 2026Shelia M. VioletteChief Scientific OfficerSale917$8.32$7,629
Oct 6, 2026Lee KalowskiCFO and PresidentSale1,301$8.32$10,824
Aug 25, 2026Lee KalowskiCFO and PresidentSale3,972$16.56$65,776
Aug 25, 2026Jodie Pope MorrisonCEOSale9,845$16.56$163,033
Aug 25, 2026Shelia M. VioletteChief Scientific OfficerSale2,798$16.56$46,335
May 28, 2026Diyong XuCorporate insiderOpen Market Purchase1,875,000$8.00$15,000,000
May 28, 2026Orbimed Advisors LLCCorporate insiderOpen Market Purchase1,875,000$8.00$15,000,000
May 28, 2026OrbiMed Capital GP VII LLCCorporate insiderOpen Market Purchase1,875,000$8.00$15,000,000
May 28, 2026OrbiMed Genesis GP LLCCorporate insiderOpen Market Purchase1,875,000$8.00$15,000,000

Common questions

QTTB insider trading FAQ

Are QTTB insiders buying or selling?
Over the last 90 days, QTTB insiders were net sellers, reporting $0.00 of open-market purchases and $320,396 of sales.
When was the last QTTB insider purchase?
No open-market insider purchase of Q32 Bio Inc. stock was reported in the last 90 days.
Where does QTTB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Q32 Bio Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.